Zetia

Merck (MSD) expands South African business

Its key products include the cholesterol drugs Vytorin (ezetimibe and simvastatin) and Zetia (ezetimibe), and the asthma therapy Singulair (montelukast sodium).

Merck & Co agrees S-P purchase

P. The companies currently collaborate on cholesterol-lowering treatments, Vytorin and Zetia. Late-stage products at S-P are said to be worth some $6bn in annual sales, the company announced

Schering-Plough sales double on statins

Schering-Plough's Q3 FY07 earnings double on soaring sales of its statin products Vytorin and Zetia. ... The campaign revealed how the combination of Zetia (ezetimibe) and Merck &Co's Zocor (simvastatin) in Vytorin helped to lower cholesterol.

Pharma news in brief

cholesterol-reducing product in the £11bn marketplace when combined with Zetia, made by Schering-Plough (SP). ... SP already sells a Zetia-Zocor (Pfizer) combination, made by Merck.

Pharma news in brief

Vytorin and Zetia sales boost Schering-Plough and Merck profits. First-quarter profits at Schering-Plough (S-P) and Merck have risen on the back of increased sales of two drugs ... Combined sales of cholesterol-lowering drugs, Vytorin and Zetia rose 54

[ Previous 5 results ] 3 4 5 6 7 8 9 [ Next 5 results ]